Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPHA2PREVENT: Alpha-2 adrenergic agonists to prevent delirium after open heart surgery
2021-001645-12Phase 3Active
- Sponsor
- Oslo University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative delirium (POD) and post-operative cognitive decline (POCD) comparing Dexmedetomidine with Clonidine (2 arms). Primary endpoint: Cumulative incidence of postoperative delirium. Started Apr 2021; status: active.
02
Drugs
dexmedetomidineclonidine
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on 2021-001645-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001645-12.